Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$136.63 USD
-1.84 (-1.33%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $136.57 -0.06 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Neurocrine Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NBIX 136.63 -1.84(-1.33%)
Will NBIX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NBIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NBIX
GRFS or NBIX: Which Is the Better Value Stock Right Now?
GRFS or NBIX: Which Is the Better Value Stock Right Now?
NBIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus
Here's What Key Metrics Tell Us About Neurocrine (NBIX) Q2 Earnings
Neurocrine Biosciences (NBIX) Q2 Earnings and Revenues Beat Estimates
Other News for NBIX
Is NBIX likely to continue higher? Directional Movement Crossover Bullish shows up after sliding 0.44%
Neurocrine price target raised to $195 from $188 at UBS
Neurocrine price target raised by $7 at UBS, here's why
Is NBIX poised for gains? Crossed Above 50 Day Moving Average shows up after rising 1.52%
UBS Analyst Raises Price Target for Neurocrine Biosciences (NBIX) | NBIX Stock News